SB

Samsara BioCapital Portfolio holdings

AUM $489M
This Quarter Return
+6.94%
1 Year Return
+135.25%
3 Year Return
+909.96%
5 Year Return
+774.56%
10 Year Return
–
AUM
$497M
AUM Growth
+$497M
Cap. Flow
+$95.6M
Cap. Flow %
19.24%
Top 10 Hldgs %
67.16%
Holding
50
New
7
Increased
5
Reduced
6
Closed
8

Top Buys

1
TIL icon
Instil Bio
TIL
$39M
2
BOLT icon
Bolt Biotherapeutics
BOLT
$24.3M
3
TERN icon
Terns Pharmaceuticals
TERN
$10.9M
4
DBTX
Decibel Therapeutics, Inc. Common Stock
DBTX
$9.39M
5
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
$7.69M

Top Sells

1
ACRS icon
Aclaris Therapeutics
ACRS
$8.57M
2
SWTX
SpringWorks Therapeutics
SWTX
$6.82M
3
EQ icon
Equillium
EQ
$2.22M
4
BCEL
Atreca, Inc. Class A Common Stock
BCEL
$1.2M
5
ATXS icon
Astria Therapeutics
ATXS
$434K

Sector Composition

1 Healthcare 97.77%
2 Financials 1.64%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NKTX icon
1
Nkarta
NKTX
$151M
$66.9M 12.35%
2,034,703
– –
KDNY
2
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$49.2M 9.08%
3,168,388
– –
FMTX
3
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$43.9M 8.09%
1,565,529
+147,000
+10% +$4.12M
TIL icon
4
Instil Bio
TIL
$182M
$39M 7.19%
+1,554,025
New +$39M
STRO icon
5
Sutro Biopharma
STRO
$72.7M
$38.1M 7.03%
1,675,579
– –
ACRS icon
6
Aclaris Therapeutics
ACRS
$209M
$25.8M 4.75%
1,022,612
-340,000
-25% -$8.57M
BOLT icon
7
Bolt Biotherapeutics
BOLT
$9.85M
$24.3M 4.48%
+737,459
New +$24.3M
ALLK
8
DELISTED
Allakos
ALLK
$16.8M 3.1%
146,259
– –
ICPT
9
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$14.8M 2.73%
640,688
+237,000
+59% +$5.47M
SYRS
10
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$14.8M 2.72%
2,189,199
– –
ISEE
11
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$14.7M 2.7%
2,372,476
– –
SWTX
12
DELISTED
SpringWorks Therapeutics
SWTX
$12.5M 2.3%
169,852
-92,720
-35% -$6.82M
TERN icon
13
Terns Pharmaceuticals
TERN
$609M
$10.9M 2.02%
+497,555
New +$10.9M
DBTX
14
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$9.39M 1.73%
+826,422
New +$9.39M
VRNA
15
Verona Pharma
VRNA
$9.16B
$9.29M 1.71%
1,111,112
– –
CVAC icon
16
CureVac
CVAC
$1.21B
$8.72M 1.61%
95,318
– –
VIRX
17
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$7.69M 1.42%
+831,625
New +$7.69M
SYRE icon
18
Spyre Therapeutics
SYRE
$996M
$7M 1.29%
883,720
– –
BCEL
19
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$6.08M 1.12%
396,835
-78,108
-16% -$1.2M
TNGX icon
20
Tango Therapeutics
TNGX
$747M
$5.56M 1.03%
500,000
– –
NVAX icon
21
Novavax
NVAX
$1.21B
$5.47M 1.01%
30,160
– –
EQ icon
22
Equillium
EQ
$62.2M
$5.47M 1.01%
764,403
-309,882
-29% -$2.22M
JYAC
23
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$4.99M 0.92%
507,041
+501,818
+9,608% +$4.94M
AVDL
24
Avadel Pharmaceuticals
AVDL
$1.43B
$4.97M 0.92%
549,250
+115,000
+26% +$1.04M
KRON
25
DELISTED
Kronos Bio
KRON
$4.87M 0.9%
166,250
– –
1
2